CIBRA Capital Ltd Takes Position in Amedisys, Inc. (NASDAQ:AMED)

CIBRA Capital Ltd bought a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 47,159 shares of the health services provider's stock, valued at approximately $4,282,000. Amedisys makes up 2.9% of CIBRA Capital Ltd's investment portfolio, making the stock its 11th largest holding. CIBRA Capital Ltd owned approximately 0.14% of Amedisys at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Blue Trust Inc. boosted its stake in Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after purchasing an additional 124 shares during the last quarter. Johnson Financial Group Inc. bought a new position in shares of Amedisys in the fourth quarter valued at approximately $55,000. Vestcor Inc bought a new position in shares of Amedisys in the fourth quarter valued at approximately $73,000. Venturi Wealth Management LLC boosted its position in shares of Amedisys by 397.4% during the fourth quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock valued at $89,000 after buying an additional 779 shares during the last quarter. Finally, Covestor Ltd grew its holdings in Amedisys by 48.8% during the fourth quarter. Covestor Ltd now owns 1,037 shares of the health services provider's stock worth $94,000 after buying an additional 340 shares in the last quarter. 94.36% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

AMED has been the topic of several recent analyst reports. Wall Street Zen cut Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. Royal Bank of Canada reissued an "outperform" rating and set a $100.00 price target on shares of Amedisys in a research report on Wednesday, April 16th. Finally, Stephens restated an "equal weight" rating and set a $101.00 price target on shares of Amedisys in a report on Tuesday, March 4th. Four analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $100.75.

Amedisys Stock Performance

Amedisys stock traded up $0.45 during mid-day trading on Friday, reaching $94.39. 220,524 shares of the company's stock were exchanged, compared to its average volume of 410,899. The business's fifty day simple moving average is $93.48 and its 200 day simple moving average is $91.59. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95. The firm has a market capitalization of $3.10 billion, a PE ratio of 37.46, a P/E/G ratio of 1.78 and a beta of 0.96.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.12. The firm had revenue of $594.78 million during the quarter, compared to analyst estimates of $597.43 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business's revenue was up 4.1% compared to the same quarter last year. During the same period last year, the firm posted $1.03 EPS. On average, sell-side analysts expect that Amedisys, Inc. will post 4.4 earnings per share for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.